-
1
-
-
0035554898
-
Multiple sclerosis: A two-stage disease
-
Steinman L. Multiple sclerosis: a two-stage disease. Nat Immunol. 2001;2:762-4.
-
(2001)
Nat Immunol.
, vol.2
, pp. 762-764
-
-
Steinman, L.1
-
2
-
-
51249090471
-
Thelper cell type 1 (Th1), th2 and th17 responses to myelin basic protein and disease activity in multiple sclerosis
-
Hedegaard CJ, Krakauer M, Bendtzen K, Lund H, Sellebjerg F, Nielsen CH. Thelper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis. Immunology. 2008;125:161-9.
-
(2008)
Immunology.
, vol.125
, pp. 161-169
-
-
Hedegaard, C.J.1
Krakauer, M.2
Bendtzen, K.3
Lund, H.4
Sellebjerg, F.5
Nielsen, C.H.6
-
3
-
-
46149083938
-
B-cells and humoral immunity in multiple sclerosis. Implications for therapy
-
Oh S, Cudrici C, Ito T, Rus H. B-cells and humoral immunity in multiple sclerosis. Implications for therapy. Immunol Res. 2007;40(3):224-34.
-
(2007)
Immunol Res.
, vol.40
, Issue.3
, pp. 224-234
-
-
Oh, S.1
Cudrici, C.2
Ito, T.3
Rus, H.4
-
4
-
-
0031748566
-
Multiple sclerosis: In situ evidence for antibody- and complement- mediated demyelination
-
DOI 10.1002/ana.410430409
-
Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H. Multiple sclerosis: in situ evidence for antibody-and complement-mediated demyelination. Ann Neurol. 1998;43:465-71. (Pubitemid 28231721)
-
(1998)
Annals of Neurology
, vol.43
, Issue.4
, pp. 465-471
-
-
Storch, M.K.1
Piddlesden, S.2
Haltia, M.3
Iivanainen, M.4
Morgan, P.5
Lassmann, H.6
-
5
-
-
0030970058
-
Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
-
DOI 10.1007/s001090050101
-
Benveniste E. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med. 1997;75 (3):165-73. (Pubitemid 27132679)
-
(1997)
Journal of Molecular Medicine
, vol.75
, Issue.3
, pp. 165-173
-
-
Benveniste, E.N.1
-
6
-
-
0029022855
-
Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyeli-tis in lewis rats
-
Huitinga I, Ruuls SR, Jung S, Van Rooijen N, Hartung HP, Dijkstra CD. Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyeli-tis in Lewis rats. Clin Exp Immunol. 1995;100:344-51.
-
(1995)
Clin Exp Immunol.
, vol.100
, pp. 344-351
-
-
Huitinga, I.1
Ruuls, S.R.2
Jung, S.3
Van Rooijen, N.4
Hartung, H.P.5
Dijkstra, C.D.6
-
7
-
-
77953639372
-
Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through tnf: A role for neutrophil recruitment?
-
Sayed BA, Christy AL, Walker ME, Brown MA. Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment? J Immunol. 2010;184(12):6891-900.
-
(2010)
J Immunol.
, vol.184
, Issue.12
, pp. 6891-6900
-
-
Sayed, B.A.1
Christy, A.L.2
Walker, M.E.3
Brown, M.A.4
-
8
-
-
34548297818
-
Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: Correlation with microglia infiltration, demyelination, and neuronal and synaptic damage
-
DOI 10.1097/nen.0b013e31812571b0, PII 0000507220070800000007
-
Vercellino M, Merola A, Piacentino C, Votta B, Capello E, Mancardi GL, et al. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol. 2007;66:732-9. (Pubitemid 47344252)
-
(2007)
Journal of Neuropathology and Experimental Neurology
, vol.66
, Issue.8
, pp. 732-739
-
-
Vercellino, M.1
Merola, A.2
Piacentino, C.3
Votta, B.4
Capello, E.5
Mancardi, G.L.6
Mutani, R.7
Giordana, M.T.8
Cavalla, P.9
-
9
-
-
0034911054
-
Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyre and axonal damage
-
DOI 10.1002/ana.1077
-
Werner P, Pitt D, Raine CS. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol. 2001;50:169-80. (Pubitemid 32738141)
-
(2001)
Annals of Neurology
, vol.50
, Issue.2
, pp. 169-180
-
-
Werner, P.1
Pitt, D.2
Raine, C.S.3
-
10
-
-
28444499085
-
Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis
-
DOI 10.1016/j.it.2005.08.014, PII S1471490605002334, Autoimmunity Special Issue
-
Steinman L, Zamvil SS. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol. 2005;26:565-71. (Pubitemid 41726443)
-
(2005)
Trends in Immunology
, vol.26
, Issue.11
, pp. 565-571
-
-
Steinman, L.1
Zamvil, S.S.2
-
11
-
-
79952815849
-
Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis
-
Healy BC, Engler D, Gholipour T, Weiner H, Bakshi R, Chitnis T. Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis. J Neurol Sci. 2011;303(1-2):109-13.
-
(2011)
J Neurol Sci.
, vol.303
, Issue.1-2
, pp. 109-13
-
-
Healy, B.C.1
Engler, D.2
Gholipour, T.3
Weiner, H.4
Bakshi, R.5
Chitnis, T.6
-
12
-
-
72649090947
-
Glatiramer acetate for the treatment of multiple sclerosis: Evidence for a dual anti-inflammatory and neuro-protective role
-
Liblau R. Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuro-protective role. J Neurol Sci. 2009;287:S17-23.
-
(2009)
J Neurol Sci.
, vol.287
-
-
Liblau, R.1
-
13
-
-
0037622124
-
Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions
-
DOI 10.1016/S0165-5728(03)00036-5
-
Vos CM, van Haastert ES, de Groot CJ, van der Valk P, de Vries HE. Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions. J Neuroimmu-nol. 2003;138:106-14. (Pubitemid 36566424)
-
(2003)
Journal of Neuroimmunology
, vol.138
, Issue.1-2
, pp. 106-114
-
-
Vos, C.M.P.1
Van Haastert, E.S.2
De Groot, C.J.A.3
Van Der Valk, P.4
De Vries, H.E.5
-
14
-
-
0025217738
-
L-Fucosidase treatment blocks myelin phagocytosis by macrophages in vitro
-
Bruck W, Friede RL. L-fucosidase treatment blocks myelin phagocytosis by macrophages in vitro. J Neuroimmunol. 1990;27:217-27. (Pubitemid 20146291)
-
(1990)
Journal of Neuroimmunology
, vol.27
, Issue.2-3
, pp. 217-227
-
-
Bruck, W.1
Friede, R.L.2
-
15
-
-
30544444119
-
Cytokine toxicity to oligodendrocyte precursors is mediated by iron
-
DOI 10.1002/glia.20235
-
Zhang X, Haaf M, Todorich B, Grosstephan E, Schieremberg H, Surguladze N, et al. Cytokine toxicity to oligodendrocyte precursors is mediated by iron. Glia. 2005;52:199-208. (Pubitemid 43078509)
-
(2005)
GLIA
, vol.52
, Issue.3
, pp. 199-208
-
-
Zhang, X.1
Haaf, M.2
Todorich, B.3
Grosstephan, E.4
Schieremberg, H.5
Surguladze, N.6
Connor, J.R.7
-
16
-
-
0034977495
-
TNF and receptors in organ-specific autoimmune disease: Multi-layered functioning mirrored in animal models
-
Kassiotis G, Kollias G. TNF and receptors in organ-specific autoimmune disease: multi-layered functioning mirrored in animal models. J Clin Invest. 2001;107:1507-8. (Pubitemid 32574636)
-
(2001)
Journal of Clinical Investigation
, vol.107
, Issue.12
, pp. 1507-1508
-
-
Kassiotis, G.1
Kollias, G.2
-
17
-
-
0032813516
-
On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease
-
DOI 10.1111/j.1600-065X.1999.tb01315.x
-
Kollias G, Douni E, Kassiotis G, Kontoyiannis D. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol Rev. 1999;169:175-94. (Pubitemid 29338732)
-
(1999)
Immunological Reviews
, vol.169
, pp. 175-194
-
-
Kollias, G.1
Douni, E.2
Kassiotis, G.3
Kontoyiannis, D.4
-
18
-
-
34547763842
-
Modulation of microglial/macro-phage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis
-
Bhasin M, Wu M, Tsirka SE. Modulation of microglial/macro-phage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis. BMC Immunol. 2007;8:10.
-
(2007)
BMC Immunol.
, vol.8
, pp. 10
-
-
Bhasin, M.1
Wu, M.2
Tsirka, S.E.3
-
19
-
-
0032103940
-
Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent
-
Martiney JA, Rajan AJ, Charles PC, Cerami A, Ulrich PC, Macphail S, et al. Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent. J Immunol. 1998;160:5588-95. (Pubitemid 28267853)
-
(1998)
Journal of Immunology
, vol.160
, Issue.11
, pp. 5588-5595
-
-
Martiney, J.A.1
Rajan, A.J.2
Charles, P.C.3
Cerami, A.4
Ulrich, P.C.5
Macphail, S.6
Tracey, K.J.7
Brosnan, C.F.8
-
20
-
-
0019468319
-
The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis
-
Brosnan CF, Bornstein MB, Bloom BR. The effects of macro-phage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol. 1981;126:614-20. (Pubitemid 11136722)
-
(1981)
Journal of Immunology
, vol.126
, Issue.2
, pp. 614-620
-
-
Brosnan, C.F.1
Bornstein, M.B.2
Bloom, B.R.3
-
21
-
-
0025015655
-
Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages
-
Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med. 1990;172:1025-33. (Pubitemid 20343201)
-
(1990)
Journal of Experimental Medicine
, vol.172
, Issue.4
, pp. 1025-1033
-
-
Huitinga, I.1
Van Rooijen, N.2
De Groot, C.J.A.3
Uitdehaag, B.M.J.4
Dijkstra, C.D.5
-
22
-
-
0032193213
-
Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice
-
Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens T. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol. 1998;161:3767-75.
-
(1998)
J Immunol.
, vol.161
, pp. 3767-3775
-
-
Tran, E.H.1
Hoekstra, K.2
Van Rooijen, N.3
Dijkstra, C.D.4
Owens, T.5
-
23
-
-
0028290252
-
Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse
-
Cecchini MG, Dominguez MG, Mocci S, Wetterwald A, Felix R, Fleisch H, et al. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development. 1994;120 (6):1357-72. (Pubitemid 24175881)
-
(1994)
Development
, vol.120
, Issue.6
, pp. 1357-1372
-
-
Cecchini, M.G.1
Dominguez, M.G.2
Mocci, S.3
Wetterwald, A.4
Felix, R.5
Fleisch, H.6
Chisholm, O.7
Hofstetter, W.8
Pollard, J.W.9
Stanley, E.R.10
-
24
-
-
78149462163
-
An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue-and tumor-associated macrophages but does not inhibit inflammation
-
MacDonald KP, Palmer JS, Cronau S, Seppanen E, Olver S, Raffelt NC, et al. An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue-and tumor-associated macrophages but does not inhibit inflammation. Blood. 2010;116:3955-63.
-
(2010)
Blood.
, vol.116
, pp. 3955-3963
-
-
MacDonald, K.P.1
Palmer, J.S.2
Cronau, S.3
Seppanen, E.4
Olver, S.5
Raffelt, N.C.6
-
25
-
-
0034032798
-
Effects of macrophage-colony-stimulating factor deficiency on the maturation of microglia and brain macrophages and on their expression of scavenger receptor
-
DOI 10.1046/j.1440-1789.2000.00286.x
-
Sasaki A, Yokoo H, Naito M, Kaizu C, Shultz LD, Nakazato Y. Effects of macrophage-colony-stimulating factor deficiency on the maturation of microglia and brain macrophages and on their expression of scavenger receptor. Neuropathology. 2000;20:134-42. (Pubitemid 30326181)
-
(2000)
Neuropathology
, vol.20
, Issue.2
, pp. 134-142
-
-
Sasaki, A.1
Yokoo, H.2
Naito, M.3
Kaizu, C.4
Shultz, L.D.5
Nakazato, Y.6
-
26
-
-
0020462249
-
Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation
-
DOI 10.1084/jem.156.5.1516
-
Wiktor-Jedrzejczak WW, Ahmed A, Szczylik C, Skelly RR. Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J Exp Med. 1982;156:1516-27. (Pubitemid 13232211)
-
(1982)
Journal of Experimental Medicine
, vol.156
, Issue.5
, pp. 1516-1527
-
-
Wiktor-Jedrzejczak, W.1
Ahmed, A.2
Szczylik, C.3
Skelly, R.R.4
-
27
-
-
33746477970
-
Identification of signaling components required for the prediction of cytokine release in RAW 264.7 macrophages
-
Pradervand S, Maurya M, Subramaniam S. Identification of signaling components required for the prediction of cytokine release in RAW 264.7 macrophages. Genome Biol. 2006;7(2): R11.
-
(2006)
Genome Biol.
, vol.7
, Issue.2
-
-
Pradervand, S.1
Maurya, M.2
Subramaniam, S.3
-
28
-
-
0033840205
-
The colony-stimulating factors and collagen-induced arthritis: Exacerbation of disease by M-CSF and G-CSF and requirement for endogenous m-csf
-
Campbell IK, Rich MJ, Bischof RJ, Hamilton JA. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol. 2000;68:144-50.
-
(2000)
J Leukoc Biol.
, vol.68
, pp. 144-150
-
-
Campbell, I.K.1
Rich, M.J.2
Bischof, R.J.3
Hamilton, J.A.4
-
29
-
-
0025045744
-
Macrophage-colony stimulating factor (M-CSF) in the cerebrospinal fluid
-
DOI 10.1016/0165-5728(90)90152-D
-
Gallo P, Pagni S, Giometto B, Piccinno MG, Bozza F, Argentiero V, et al. Macrophage-colony stimulating factor (M-CSF) in the cerebrospinal fluid. J Neuroimmunol. 1990;29:105-12. (Pubitemid 20283787)
-
(1990)
Journal of Neuroimmunology
, vol.29
, Issue.1-3
, pp. 105-112
-
-
Gallo, P.1
Pagni, S.2
Giometto, B.3
Piccinno, M.G.4
Bozza, F.5
Argentiero, V.6
Tavolato, B.7
-
30
-
-
0032961268
-
Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families
-
DOI 10.1038/sj.ejhg.5200301
-
D'Alfonso S, Nistico L, Zavattari P, Marrosu MG, Murru R, Lai M, et al. Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families. Eur J Hum Genet. 1999;7:377-85. (Pubitemid 29213745)
-
(1999)
European Journal of Human Genetics
, vol.7
, Issue.3
, pp. 377-385
-
-
D'Alfonso, S.1
Nistico, L.2
Zavattari, P.3
Marrosu, M.G.4
Murru, R.5
Lai, M.6
Massacesi, L.7
Ballerini, C.8
Gestri, D.9
Salvetti, M.10
Ristori, G.11
Bomprezzi, R.12
Trojano, M.13
Liguori, M.14
Gambi, D.15
Quattrone, A.16
Fruci, D.17
Cucca, F.18
Richiardi, P.M.19
Tosi, R.20
more..
-
31
-
-
0028203591
-
Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie
-
Campbell IL, Eddleston M, Kemper P, Oldstone MB, Hobbs MV. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J Virol. 1994;68:2383-7. (Pubitemid 24091917)
-
(1994)
Journal of Virology
, vol.68
, Issue.4
, pp. 2383-2387
-
-
Campbell, I.L.1
Eddleston, M.2
Kemper, P.3
Oldstone, M.B.A.4
Hobbs, M.V.5
-
32
-
-
0141533210
-
New roles for astrocytes (stars at last)
-
DOI 10.1016/j.tins.2003.08.006
-
Ransom B, Behar T, Nedergaard M. New roles for astrocytes (stars at last). Trends Neurosci. 2003;26:520-2. (Pubitemid 37176905)
-
(2003)
Trends in Neurosciences
, vol.26
, Issue.10
, pp. 520-522
-
-
Ransom, B.1
Behar, T.2
Nedergaard, M.3
-
33
-
-
34548206670
-
Astrocytes-Friends or foes in multiple sclerosis?
-
Williams A, Piaton G, Lubetzki C. Astrocytes-friends or foes in multiple sclerosis? Glia. 2007;55:1300-12.
-
(2007)
Glia.
, vol.55
, pp. 1300-1312
-
-
Williams, A.1
Piaton, G.2
Lubetzki, C.3
-
34
-
-
33751560062
-
Astrogliosis in EAE spinal cord: Derivation from radial glia, and relationships to oligodendroglia
-
Bannerman P, Hahn A, Soulika A, Gallo V, Pleasure D. Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia. Glia. 2006;55(1):57-64.
-
(2006)
Glia.
, vol.55
, Issue.1
, pp. 57-64
-
-
Bannerman, P.1
Hahn, A.2
Soulika, A.3
Gallo, V.4
Pleasure, D.5
-
35
-
-
0033571849
-
Platelet-derived growth factor-mediated signal transduction underlying astrocyte proliferation: Site of ethanol action
-
Luo J, Miller MW. Platelet-derived growth factor-mediated signal transduction underlying astrocyte proliferation: site of ethanol action. J Neurosci. 1999;19:10014-25. (Pubitemid 30226673)
-
(1999)
Journal of Neuroscience
, vol.19
, Issue.22
, pp. 10014-10025
-
-
Luo, J.1
Miller, M.W.2
-
36
-
-
38849085278
-
Up-regulation of platelet-derived growth factor by peripheral-blood leukocytes during experimental allergic encephalomyelitis
-
DOI 10.1002/jnr.21497
-
Koehler NK, Roebbert M, Dehghani K, Ballmaier M, Claus P, von Hoersten S, et al. Up-regulation of platelet-derived growth factor by peripheral-blood leukocytes during experimental allergic encephalomyelitis. J Neurosci Res. 2008;86:392-402. (Pubitemid 351196744)
-
(2008)
Journal of Neuroscience Research
, vol.86
, Issue.2
, pp. 392-402
-
-
Koehler, N.K.U.1
Roebbert, M.2
Dehghani, K.3
Ballmaier, M.4
Claus, P.5
Von Hoersten, S.6
Shing, M.7
Odin, P.8
Strehlau, J.9
Heidenreich, F.10
-
37
-
-
33749446861
-
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis
-
DOI 10.1172/JCI28546
-
Paniagua RT. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J Clin Invest. 2006;116(10):2633-42. (Pubitemid 44511627)
-
(2006)
Journal of Clinical Investigation
, vol.116
, Issue.10
, pp. 2633-2642
-
-
Paniagua, R.T.1
Sharpe, O.2
Ho, P.P.3
Chan, S.M.4
Chang, A.5
Higgins, J.P.6
Tomooka, B.H.7
Thomas, F.M.8
Song, J.J.9
Goodman, S.B.10
Lee, D.M.11
Genovese, M.C.12
Utz, P.J.13
Steinman, L.14
Robinson, W.H.15
-
38
-
-
57749094961
-
Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice
-
Louvet C, Szot G, Lang J, Lee M, Martinier N, Bollag G, et al. Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci USA. 2008;105(48):18895-900.
-
(2008)
Proc Natl Acad Sci USA.
, vol.105
, Issue.48
, pp. 18895-18900
-
-
Louvet, C.1
Szot, G.2
Lang, J.3
Lee, M.4
Martinier, N.5
Bollag, G.6
-
39
-
-
34248647881
-
Active induction of experimental allergic encephalomyelitis
-
DOI 10.1038/nprot.2006.285, PII NPROT.2006.285
-
Stromnes IM, Goverman JM. Active induction of experimental allergic encephalomyelitis. Nat Protoc. 2006;1:1810-9. (Pubitemid 46773300)
-
(2006)
Nature Protocols
, vol.1
, Issue.4
, pp. 1810-1819
-
-
Stromnes, I.M.1
Goverman, J.M.2
-
40
-
-
77953269844
-
C-fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis
-
Paniagua RT, Chang A, Mariano MM, Stein EA, Wang Q, Lindstrom TM, et al. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis. Arthritis Res Ther. 2010;12(1):R32.
-
(2010)
Arthritis Res Ther.
, vol.12
, Issue.1
-
-
Paniagua, R.T.1
Chang, A.2
Mariano, M.M.3
Stein, E.A.4
Wang, Q.5
Lindstrom, T.M.6
-
41
-
-
0035810147
-
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
-
DOI 10.1056/NEJM200104053441401
-
Druker B, Talpaz M, Resta D, Peng B, Buchdunger E, Ford J, et al. Sawyers C (2001) Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 2001;344:1031-7. (Pubitemid 32267972)
-
(2001)
New England Journal of Medicine
, vol.344
, Issue.14
, pp. 1031-1037
-
-
Druker, B.J.1
Talpaz, M.2
Resta, D.J.3
Peng, B.4
Buchdunger, E.5
Ford, J.M.6
Lydon, N.B.7
Kantarjian, H.8
Capdeville, R.9
Ohno-Jones, S.10
Sawyers, C.L.11
-
42
-
-
2542466775
-
Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer
-
DOI 10.1158/1078-0432.CCR-0957-03
-
Wolff NC, Randle DE, Egorin MJ, Minna JD, Ilaria Jr RL. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer. Clin Cancer Res. 2004;10:3528-34. (Pubitemid 38685463)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.10
, pp. 3528-3534
-
-
Wolff, N.C.1
Randle, D.E.2
Egorin, M.J.3
Minna, J.D.4
Ilaria Jr., R.L.5
-
43
-
-
58149511920
-
Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor
-
Huynh H, Lee JW, Chow PK, Ngo VC, Lew GB, Lam IW, et al. Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor. Mol Cancer Ther. 2009;8:152-9.
-
(2009)
Mol Cancer Ther.
, vol.8
, pp. 152-159
-
-
Huynh, H.1
Lee, J.W.2
Chow, P.K.3
Ngo, V.C.4
Lew, G.B.5
Lam, I.W.6
-
44
-
-
67649637107
-
Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib
-
Chung EJ, Yoo S, Lim HJ, Byeon SH, Lee JH, Koh HJ. Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib. Br J Ophthalmol. 2009;93:958-63.
-
(2009)
Br J Ophthalmol.
, vol.93
, pp. 958-963
-
-
Chung, E.J.1
Yoo, S.2
Lim, H.J.3
Byeon, S.H.4
Lee, J.H.5
Koh, H.J.6
-
45
-
-
0141634089
-
Results of phase i pharmacokinetic and pharmacodynamic studies of the raf kinase inhibitor BAY 43-9006 in patients with solid tumors
-
Strumberg D, Voliotis D, Moeller JG, Hilger RA, Richly H, Kredtke S, et al. Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors. Int J Clin Pharmacol Ther. 2002;40:580-1.
-
(2002)
Int J Clin Pharmacol Ther.
, vol.40
, pp. 580-581
-
-
Strumberg, D.1
Voliotis, D.2
Moeller, J.G.3
Hilger, R.A.4
Richly, H.5
Kredtke, S.6
-
46
-
-
27644436741
-
Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580
-
DOI 10.1073/pnas.0502000102
-
Conway JG, McDonald B, Parham J, Keith B, Rusnak DW, Shaw E, et al. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cfms kinase inhibitor gw2580. Proc Natl Acad Sci USA. 2005;102(44):16078-83. (Pubitemid 41552870)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.44
, pp. 16078-16083
-
-
Conway, J.G.1
McDonald, B.2
Parham, J.3
Keith, B.4
Rusnak, D.W.5
Shaw, E.6
Jansen, M.7
Lin, P.8
Payne, A.9
Crosby, R.M.10
Johnson, J.H.11
Frick, L.12
Lin, M.-H.J.13
Depee, S.14
Tadepalli, S.15
Votta, B.16
James, I.17
Fuller, K.18
Chambers, T.J.19
Kull, F.C.20
Chamberlain, S.D.21
Hutchins, J.T.22
more..
-
47
-
-
0032752573
-
Endogenous presentation of self myelin epitopes by cns-resident apcs in theiler's virus-infected mice
-
Katz-Levy Y, Neville KL, Girvin AM, Vanderlugt CL, Pope JG, Tan LJ, et al. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. J Clin Invest. 1999;104:599-610.
-
(1999)
J Clin Invest.
, vol.104
, pp. 599-610
-
-
Katz-Levy, Y.1
Neville, K.L.2
Girvin, A.M.3
Vanderlugt, C.L.4
Pope, J.G.5
Tan, L.J.6
-
48
-
-
20344362911
-
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours
-
DOI 10.1038/sj.bjc.6602584
-
Awada A, Hendlisz A, Gil T, Bartholomeus S, Mano M, De Valeriola D, et al. Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours. Br J Cancer. 2005;92 (10):1855-61. (Pubitemid 40826133)
-
(2005)
British Journal of Cancer
, vol.92
, Issue.10
, pp. 1855-1861
-
-
Awada, A.1
Hendlisz, A.2
Gil, T.3
Bartholomeus, S.4
Mano, M.5
De Valeriola, D.6
Strumberg, D.7
Brendel, E.8
Haase, C.G.9
Schwartz, B.10
Piccart, M.11
-
49
-
-
0036401105
-
BAY 43-9006: Preclinical data
-
DOI 10.2174/1381612023393026
-
Wilhelm S, Chien DS. BAY 43-9006: preclinical data. Curr Pharm Des. 2002;8:2255-7. (Pubitemid 35189898)
-
(2002)
Current Pharmaceutical Design
, vol.8
, Issue.25
, pp. 2255-2257
-
-
Wilhelm, S.1
Chien, D.-S.2
-
50
-
-
55749088393
-
Preclinical overview of sorafenib, a multikinase inhibitor that targets both raf and VEGF and PDGF receptor tyrosine kinase signaling
-
Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther. 2008;7(10):3129-40.
-
(2008)
Mol Cancer Ther.
, vol.7
, Issue.10
, pp. 3129-3140
-
-
Wilhelm, S.M.1
Adnane, L.2
Newell, P.3
Villanueva, A.4
Llovet, J.M.5
Lynch, M.6
-
51
-
-
33646468642
-
Pharmacodynamic monitoring of BAY 43-9006 (Sorafenib) in phase i clinical trials involving solid tumor and aml/mds patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells
-
Tong FK, Chow S, HD. Pharmacodynamic monitoring of BAY 43-9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells. Cytometry B Clin Cytom. 2006;70(3):107-14.
-
(2006)
Cytometry B Clin Cytom.
, vol.70
, Issue.3
, pp. 107-114
-
-
Tong, F.K.1
Hd, C.S.2
-
52
-
-
27644436741
-
Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580
-
DOI 10.1073/pnas.0502000102
-
Conway JG, McDonald B, Parham J, Keith B, Rusnak DW, Shaw E, et al. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. Proc Natl Acad Sci USA. 2005;102:16078-83. (Pubitemid 41552870)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.44
, pp. 16078-16083
-
-
Conway, J.G.1
McDonald, B.2
Parham, J.3
Keith, B.4
Rusnak, D.W.5
Shaw, E.6
Jansen, M.7
Lin, P.8
Payne, A.9
Crosby, R.M.10
Johnson, J.H.11
Frick, L.12
Lin, M.-H.J.13
Depee, S.14
Tadepalli, S.15
Votta, B.16
James, I.17
Fuller, K.18
Chambers, T.J.19
Kull, F.C.20
Chamberlain, S.D.21
Hutchins, J.T.22
more..
-
53
-
-
57049183567
-
Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma
-
Valcamonico F, Ferrari V, Amoroso V, Rangoni G, Simoncini E, Marpicati P, et al. Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma. J Neurooncol. 2009;9 (1):47-50.
-
(2009)
J Neurooncol.
, vol.9
, Issue.1
, pp. 47-50
-
-
Valcamonico, F.1
Ferrari, V.2
Amoroso, V.3
Rangoni, G.4
Simoncini, E.5
Marpicati, P.6
-
54
-
-
67650312033
-
Imatinib is a substrate for various multidrug resistance proteins
-
Czyzewski K, Styczynski J. Imatinib is a substrate for various multidrug resistance proteins. Neoplasma. 2009;56:202-7.
-
(2009)
Neoplasma.
, vol.56
, pp. 202-207
-
-
Czyzewski, K.1
Styczynski, J.2
-
55
-
-
0035966659
-
Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune enceph-alomyelitis
-
Tonra JR, Reiseter BS, Kolbeck R, Nagashima K, Robertson R, Keyt B, et al. Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune enceph-alomyelitis. J Comp Neurol. 2001;430:131-44.
-
(2001)
J Comp Neurol.
, vol.430
, pp. 131-144
-
-
Tonra, J.R.1
Reiseter, B.S.2
Kolbeck, R.3
Nagashima, K.4
Robertson, R.5
Keyt, B.6
-
56
-
-
41949142501
-
The selective M-CSF receptor tyrosine kinase inhibitor ki20227 suppresses experimental autoimmune encephalomyelitis
-
Uemura Y, Ohno H, Ohzeki Y, Takanashi H, Murooka H, Kubo K, et al. The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis. J Neuroimmunol. 2008;195:73-80.
-
(2008)
J Neuroimmunol.
, vol.195
, pp. 73-80
-
-
Uemura, Y.1
Ohno, H.2
Ohzeki, Y.3
Takanashi, H.4
Murooka, H.5
Kubo, K.6
-
57
-
-
0032748352
-
The role of tnfalpha and lymphotoxin in demyelinating disease
-
Lock C, Oksenberg J, Steinman L. The role of TNFalpha and lymphotoxin in demyelinating disease. Ann Rheum Dis. 1999;58 Suppl 1:I121-8.
-
(1999)
Ann Rheum Dis.
, vol.58
, Issue.SUPPL. 1
-
-
Lock, C.1
Oksenberg, J.2
Steinman, L.3
-
58
-
-
0025773147
-
Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis
-
Sharief MK, Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med. 1991;325:467-72.
-
(1991)
N Engl J Med.
, vol.325
, pp. 467-472
-
-
Sharief, M.K.1
Hentges, R.2
-
59
-
-
0035960624
-
Onset of multiple sclerosis associated with anti-TNF therapy
-
Sicotte NL, Voshkul RR. Onset of multiple sclerosis associated with anti-TNF therapy. Neurology. 2001;57(10):1885-8. (Pubitemid 33096700)
-
(2001)
Neurology
, vol.57
, Issue.10
, pp. 1885-1888
-
-
Sicotte, N.L.1
Voskuhl, R.R.2
-
60
-
-
0035464263
-
Demyelinating and Neurologic Events Reported in Association with Tumor Necrosis Factor α Antagonism: By What Mechanisms Could Tumor Necrosis Factor a Antagonists Improve Rheumatoid Arthritis but Exacerbate Multiple Sclerosis?
-
DOI 10.1002/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6
-
Robinson WH, Genovese MC, Moreland LW. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum. 2001;44:1977-83. (Pubitemid 33644038)
-
(2001)
Arthritis and Rheumatism
, vol.44
, Issue.9
, pp. 1977-1983
-
-
Robinson, W.H.1
Genovese, M.C.2
Moreland, L.W.3
-
61
-
-
77952553026
-
Transcriptional effects of colony-stimulating factor-1 in mouse macrophages
-
El Chartouni C, Benner C, Eigner M, Lichtinger M, Rehli M. Transcriptional effects of colony-stimulating factor-1 in mouse macrophages. Immunobiology. 2010;215(6):466-74.
-
(2010)
Immunobiology.
, vol.215
, Issue.6
, pp. 466-474
-
-
El Chartouni, C.1
Benner, C.2
Eigner, M.3
Lichtinger, M.4
Rehli, M.5
-
62
-
-
13844262625
-
Nitric-oxide-dependent and independent mechanisms of protection from CNS inflammation during Th1-mediated autoimmunity: Evidence from EAE in iNOS KO mice
-
DOI 10.1016/j.jneuroim.2004.11.004
-
Dalton D, Wittmer S. Nitric-oxide-dependent and independent mechanisms of protection from CNS inflammation during Th1-mediated autoimmunity: evidence from EAE in iNOS KO mice. J Neuroimmunol. 2005;160(1-2):110-21. (Pubitemid 40248600)
-
(2005)
Journal of Neuroimmunology
, vol.160
, Issue.1-2
, pp. 110-121
-
-
Dalton, D.K.1
Wittmer, S.2
-
63
-
-
0037162003
-
Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages
-
DOI 10.1038/sj/onc/1205409
-
Rovida E, Baccarini M, Olivotto M, Dello Sbarba P. Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages. Oncogene. 2002;21:3670-6. (Pubitemid 34620530)
-
(2002)
Oncogene
, vol.21
, Issue.23
, pp. 3670-3676
-
-
Rovida, E.1
Baccarini, M.2
Olivotto, M.3
Dello Sbarba, P.4
-
65
-
-
45749136367
-
Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl) oxy) benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats?
-
DOI 10.1124/jpet.107.129429
-
Conway J, Pink H, Bergquist M, Han B, Depee S, Tadepalli S, et al. Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy) benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats. J Pharmacol Exp Ther. 2008;326(1):41-50. (Pubitemid 351872132)
-
(2008)
Journal of Pharmacology and Experimental Therapeutics
, vol.326
, Issue.1
, pp. 41-50
-
-
Conway, J.G.1
Pink, H.2
Bergquist, M.L.3
Han, B.4
Depee, S.5
Tadepalli, S.6
Lin, P.7
Crumrine, R.C.8
Binz, J.9
Clark, R.L.10
Selph, J.L.11
Stimpson, S.A.12
Hutchins, J.T.13
Chamberlain, S.D.14
Brodie, T.A.15
-
66
-
-
0036135085
-
Enhanced expression of NGF receptors in multiple sclerosis lesions
-
Valdo P, Stegagno C, Mazzucco S, Zuliani E, Zanusso G, Moretto G, et al. Enhanced expression of NGF receptors in multiple sclerosis lesions. J Neuropathol Exp Neurol. 2002;61:91-8. (Pubitemid 34027724)
-
(2002)
Journal of Neuropathology and Experimental Neurology
, vol.61
, Issue.1
, pp. 91-98
-
-
Valdo, P.1
Stegagno, C.2
Mazzucco, S.3
Zuliani, E.4
Zanusso, G.5
Moretto, G.6
Raine, C.S.7
Bonetti, B.8
|